Schwann Cell Transplantation Subdues the Pro-Inflammatory Innate Immune Cell Response after Spinal Cord Injury

The transplantation of Schwann cells (SCs) has been shown to provide tissue preservation and support axon growth and remyelination as well as improve functional recovery across a diverse range of experimental spinal cord injury (SCI) paradigms. The autologous use of SCs has progressed to Phase 1 SCI clinical trials in humans where their use has been shown to be both feasible and safe. The contribution of immune modulation to the protective and reparative actions of SCs within the injured spinal cord remains largely unknown. In the current investigation, the ability of SC transplants to alter the innate immune response after contusive SCI in the rat was examined. SCs were intraspinally transplanted into the lesion site at 1 week following a thoracic (T8) contusive SCI. Multicolor flow cytometry and immunohistochemical analysis of specific phenotypic markers of pro- and anti-inflammatory microglia and macrophages as well as cytokines at 1 week after SC transplantation was employed. The introduction of SCs significantly attenuated the numbers of cluster of differentiation molecule 11B (CD11b)+, cluster of differentiation molecule 68 (CD68)+, and ionized calcium-binding adapter molecule 1 (Iba1)+ immune cells within the lesion implant site, particularly those immunoreactive for the pro-inflammatory marker, inducible nitric oxide synthase (iNOS). Whereas numbers of anti-inflammatory CD68+ Arginase-1 (Arg1+) iNOS− cells were not altered by SC transplantation, CD68+ cells of an intermediate, Arg1+ iNOS+ phenotype were increased by the introduction of SCs into the injured spinal cord. The morphology of Iba1+ immune cells was also markedly altered in the SC implant, being elongated and in alignment with SCs and in-growing axons versus their amoeboid form after SCI alone. Examination of pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), and anti-inflammatory cytokines, interleukin-4 (IL-4) and interleukin-10 (IL-10), by multicolor flow cytometry analysis showed that their production in CD11b+ cells was unaltered by SC transplantation at 1 week post-transplantation. The ability of SCs to subdue the pro-inflammatory iNOS+ microglia and macrophage phenotype after intraspinal transplantation may provide an important contribution to the neuroprotective effects of SCs within the sub-acute SCI setting.

[1]  C. Schmidt,et al.  Decellularized peripheral nerve supports Schwann cell transplants and axon growth following spinal cord injury. , 2018, Biomaterials.

[2]  S. David,et al.  Myeloid cell responses after spinal cord injury , 2018, Journal of Neuroimmunology.

[3]  T. Papenfuss,et al.  CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions , 2018, Front. Immunol..

[4]  Diana M. Mitchell,et al.  Dynamic changes in microglial and macrophage characteristics during degeneration and regeneration of the zebrafish retina , 2018, Journal of Neuroinflammation.

[5]  K. Anderson,et al.  Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury. , 2017, Journal of neurotrauma.

[6]  M. Fehlings,et al.  Efficacy and Safety of Methylprednisolone Sodium Succinate in Acute Spinal Cord Injury: A Systematic Review , 2017, Global spine journal.

[7]  M. Norenberg,et al.  Human Schwann cells exhibit long‐term cell survival, are not tumorigenic and promote repair when transplanted into the contused spinal cord , 2017, Glia.

[8]  B. Fontaine,et al.  Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry. , 2017, Journal of visualized experiments : JoVE.

[9]  S. Kalinin,et al.  Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma , 2017, Neuroscience Letters.

[10]  Jie-yuan Zhang,et al.  The Effects of Co-transplantation of Olfactory Ensheathing Cells and Schwann Cells on Local Inflammation Environment in the Contused Spinal Cord of Rats , 2017, Molecular Neurobiology.

[11]  J. Gensel,et al.  Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment , 2017, Scientific Reports.

[12]  V. Rahimi-Movaghar,et al.  The efficacy of Schwann cell transplantation on motor function recovery after spinal cord injuries in animal models: A systematic review and meta-analysis , 2016, Journal of Chemical Neuroanatomy.

[13]  D. Prough,et al.  Human Neural Stem Cell Transplantation-Mediated Alteration of Microglial/Macrophage Phenotypes after Traumatic Brain Injury , 2016, Cell transplantation.

[14]  A. Harvey,et al.  Intravenous Transplantation of Mesenchymal Progenitors Distribute Solely to the Lungs and Improve Outcomes in Cervical Spinal Cord Injury , 2016, Stem cells.

[15]  M. Fehlings,et al.  Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury , 2016, Stem cells translational medicine.

[16]  R. Mirsky,et al.  The repair Schwann cell and its function in regenerating nerves , 2016, The Journal of physiology.

[17]  Yong Xu,et al.  Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines , 2016, Journal of Neuroinflammation.

[18]  J. A. Stratton,et al.  Macrophage polarization in nerve injury: do Schwann cells play a role? , 2016, Neural regeneration research.

[19]  Phillip G. Popovich,et al.  Novel Markers to Delineate Murine M1 and M2 Macrophages , 2015, PloS one.

[20]  J. Silver,et al.  Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury , 2015, Scientific Reports.

[21]  J. Gensel,et al.  Macrophage activation and its role in repair and pathology after spinal cord injury , 2015, Brain Research.

[22]  A. Lloyd,et al.  Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves , 2015, Cell.

[23]  Q. Shu,et al.  Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization , 2015, Stem cells international.

[24]  E. Itoi,et al.  Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus , 2015, Reviews in the neurosciences.

[25]  A. M. Martinez,et al.  Neurotrauma and Inflammation: CNS and PNS Responses , 2015, Mediators of inflammation.

[26]  C. H. Ma,et al.  Bipolar/rod-shaped microglia are proliferating microglia with distinct M1/M2 phenotypes , 2014, Scientific Reports.

[27]  D. Ditor,et al.  Immune dysfunction and chronic inflammation following spinal cord injury , 2014, Spinal Cord.

[28]  S. Fumagalli,et al.  Bone Marrow Mesenchymal Stromal Cells Drive Protective M2 Microglia Polarization After Brain Trauma , 2014, Neurotherapeutics.

[29]  M. Jeong,et al.  Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages , 2014, Experimental & Molecular Medicine.

[30]  A Suzumura,et al.  Minocycline selectively inhibits M1 polarization of microglia , 2013, Cell Death and Disease.

[31]  Herbert F. Jelinek,et al.  Quantitating the subtleties of microglial morphology with fractal analysis , 2013, Front. Cell. Neurosci..

[32]  R. Bellamkonda,et al.  Effect of modulating macrophage phenotype on peripheral nerve repair. , 2012, Biomaterials.

[33]  Gregor Bieri,et al.  Neural Progenitor Cells Regulate Microglia Functions and Activity States , 2012, Nature Neuroscience.

[34]  Samik Patel,et al.  The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury , 2012, PloS one.

[35]  H. Baba,et al.  Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. , 2012, Journal of neurotrauma.

[36]  U. Rutishauser,et al.  Extensive cell migration, axon regeneration, and improved function with polysialic acid‐modified Schwann cells after spinal cord injury , 2012, Glia.

[37]  P. Popovich,et al.  Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury , 2011, Journal of Neuroinflammation.

[38]  K. Beck,et al.  Quantitative Assessment of Immune Cells in the Injured Spinal Cord Tissue by Flow Cytometry: a Novel Use for a Cell Purification Method , 2011, Journal of visualized experiments : JoVE.

[39]  K. Houkin,et al.  Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome , 2010, Brain Research.

[40]  M. Ghosh,et al.  Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord. , 2010, Journal of neurotrauma.

[41]  T. Woodruff,et al.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. , 2010, Brain : a journal of neurology.

[42]  Jessica K. Alexander,et al.  Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord , 2009, The Journal of Neuroscience.

[43]  D. Pearse,et al.  Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats , 2009, The Journal of comparative neurology.

[44]  J. Steeves,et al.  Outcome measures in spinal cord injury: recent assessments and recommendations for future directions , 2009, Spinal Cord.

[45]  R. Martini,et al.  Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease , 2008, Glia.

[46]  D. Pearse,et al.  Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery , 2007, Glia.

[47]  S. Lacroix,et al.  Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved , 2007, The Journal of comparative neurology.

[48]  D. Pearse,et al.  Survival, Integration, and Axon Growth Support of Glia Transplanted into the Chronically Contused Spinal Cord , 2005, Cell transplantation.

[49]  M. Filbin,et al.  cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury , 2004, Nature Medicine.

[50]  R. Mirsky,et al.  Denervated Schwann Cells Attract Macrophages by Secretion of Leukemia Inhibitory Factor (LIF) and Monocyte Chemoattractant Protein-1 in a Process Regulated by Interleukin-6 and LIF , 2002, The Journal of Neuroscience.

[51]  P. Popovich,et al.  Alterations in immune cell phenotype and function after experimental spinal cord injury. , 2001, Journal of neurotrauma.

[52]  J. Turek,et al.  The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. , 2000, The Journal of experimental biology.

[53]  C. Bajaj,et al.  Two- and three-dimensional computer graphic evaluation of the subacute spinal cord injury , 1998, Journal of the Neurological Sciences.

[54]  J. Damoiseaux,et al.  Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. , 1994, Immunology.

[55]  Ann Saada,et al.  Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2 , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  V. Perry,et al.  Role of macrophages in peripheral nerve degeneration and repair , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[57]  R. Bunge,et al.  Isolation and functional characterization of Schwann cells derived from adult peripheral nerve , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  G Stoll,et al.  Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation , 1989, Journal of neurocytology.

[59]  F. Djouad,et al.  Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages. , 2017, Results and problems in cell differentiation.

[60]  S. Strickland,et al.  Peripheral regeneration. , 2007, Annual review of neuroscience.

[61]  J. A. Gruner,et al.  A monitored contusion model of spinal cord injury in the rat. , 1992, Journal of neurotrauma.

[62]  R. Bunge,et al.  Role of peripheral nerve extracellular matrix in Schwann cell function and in neurite regeneration. , 1989, Developmental neuroscience.